NPCA 2015 Annual Report

Name: NPCA 2015 Annual Report
Creator: Healthcare Quality Improvement Partnership
Published: 2024-05-31T01:33:28+08:00

data.gov.uk2015-12-02 更新2024-05-31 收录

前列腺癌

临床审计

数据链接：

https://www.data.gov.uk/dataset/ec78b3fb-5205-430a-9617-bbaee11277d2/npca-2015-annual-report 数据链接链接失效反馈

官方服务：

资源简介：

NPCA Second Annual Report 2015 The National Prostate Cancer Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit Programme in...

提供机构：

Healthcare Quality Improvement Partnership

Treatment patterns and healthcare resource utilization in patients with metastatic hormone-sensitive prostate cancer and nonmetastatic castration-resistant prostate cancer in China: a real-world observational study

前列腺癌

医疗资源利用

This study assessed the treatment patterns, healthcare resource utilization (HRU), costs, and annual prevalence and incidence of metastatic hormone-sensitive prostate cancer (mHSPC) and nonmetastatic

DataCite Commons2026-03-17 更新60

Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis

前列腺癌

环形RNA

Circular RNAs play crucial regulatory roles in the progression of various cancers. Nevertheless, the underlying mechanisms of circRNAs in prostate cancer (PCa) proliferation and metastasis remain larg

DataCite Commons2024-08-05 更新50

Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223

前列腺癌

生存期预测

ABSTRACT Objective Radium-223(223Ra) is indicated for patients (p) with metastatic castration resistant prostate cancer (mCRCP). Objectives The aim of this study was to evaluate the role of baseline c

DataCite Commons2021-03-24 更新40

DataSheet_1_Burden of Prostate Cancer in China, 1990–2019: Findings From the 2019 Global Burden of Disease Study.csv

前列腺癌

疾病负担

Our study is the first to illustrate the age and geographic distribution differences in the epidemiology of prostate cancer from 1990 to 2019 in China. Prostate cancer (PC) is a malignant tumor derive

NIAID Data Ecosystem50

High expression of ladinin-1 (LAD1) predicts adverse outcomes: a new candidate docetaxel resistance gene for prostatic cancer (PCa)

前列腺癌

基因表达

Docetaxel resistance is one of the major obstacles that undermine the treatment outcome of PCa. Exploring molecular mechanisms associated with docetaxel resistance could provide insights into the form

Mendeley Data2024-06-25 更新40

NPCA 2015 Annual Report

资源简介：

相关数据集